Literature DB >> 17490956

Effects of fish-oil supplementation on myocardial fatty acids in humans.

Robert G Metcalf1, Michael J James, Robert A Gibson, James Rm Edwards, John Stubberfield, Robert Stuklis, Kurt Roberts-Thomson, Glenn D Young, Leslie G Cleland.   

Abstract

BACKGROUND: Increased fish or fish-oil consumption is associated with reduced risk of cardiac mortality, especially sudden death. This benefit putatively arises from the incorporation of the long-chain n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) into cardiomyocyte phospholipids.
OBJECTIVE: The study examined the kinetics of incorporation of n-3 fatty acids into human myocardial membrane phospholipids during supplementation with fish oil and alpha-linolenic acid-rich flaxseed oil.
DESIGN: Patients with low self-reported fish intake (<1 fish meal/wk and no oil supplements) accepted for elective cardiac surgery involving cardiopulmonary bypass were randomly allocated to 1 of 6 groups: no supplement; fish oil (6 g EPA+DHA/d) for either 7, 14, or 21 d before surgery; flaxseed oil; or olive oil (both 10 mL/d for 21 d before surgery). Right atrial appendage tissue removed during surgery and blood collected at enrollment and before surgery were analyzed for phospholipid fatty acids.
RESULTS: Surgery rescheduling resulted in a range of treatment times from 7 to 118 d. In the fish-oil-treated subjects, accumulation of EPA and DHA in the right atrium was curvilinear with time and reached a maximum at approximately 30 d of treatment and displaced mainly arachidonic acid. Flaxseed oil supplementation yielded a small increase in atrial EPA but not DHA, whereas olive oil did not significantly change atrial n-3 fatty acids.
CONCLUSION: The results of the present study show that dietary n-3 fatty acids are rapidly incorporated into human myocardial phospholipids at the expense of arachidonic acid during high-dose fish-oil supplementation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17490956     DOI: 10.1093/ajcn/85.5.1222

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  65 in total

Review 1.  (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?

Authors:  Dariush Mozaffarian; Jason H Y Wu
Journal:  J Nutr       Date:  2012-01-25       Impact factor: 4.798

2.  Activation of vascular BK channels by docosahexaenoic acid is dependent on cytochrome P450 epoxygenase activity.

Authors:  Ru-xing Wang; Qiang Chai; Tong Lu; Hon-Chi Lee
Journal:  Cardiovasc Res       Date:  2010-12-27       Impact factor: 10.787

3.  Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications.

Authors:  Arja T Erkkilä; Ursula S Schwab; Vanessa D F de Mello; Tiina Lappalainen; Hanna Mussalo; Seppo Lehto; Virpi Kemi; Christel Lamberg-Allardt; Matti I J Uusitupa
Journal:  Eur J Nutr       Date:  2008-07-29       Impact factor: 5.614

4.  Fish Oil and Perioperative Bleeding.

Authors:  Emmanuel Akintoye; Prince Sethi; William S Harris; Paul A Thompson; Roberto Marchioli; Luigi Tavazzi; Roberto Latini; Mias Pretorius; Nancy J Brown; Peter Libby; Dariush Mozaffarian
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-11

5.  Effect of supplemented intake of omega-3 fatty acids on arrhythmias in patients with ICD: fish oil therapy may reduce ventricular arrhythmia.

Authors:  Dalit Weisman; Roy Beinart; Aharon Erez; Nira Koren-Morag; Ilan Goldenberg; Michael Eldar; Michael Glikson; David Luria
Journal:  J Interv Card Electrophysiol       Date:  2017-06-29       Impact factor: 1.900

Review 6.  Dietary fat and heart failure: moving from lipotoxicity to lipoprotection.

Authors:  William C Stanley; Erinne R Dabkowski; Rogerio F Ribeiro; Kelly A O'Connell
Journal:  Circ Res       Date:  2012-03-02       Impact factor: 17.367

Review 7.  Unknown biological effects of L-glucose, ALA, and PUFA.

Authors:  Katsuya Yamada; Daisuke Sato; Takao Nakamura; Hizuru Amano; Yuji Morimoto
Journal:  J Physiol Sci       Date:  2017-05-30       Impact factor: 2.781

Review 8.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

9.  Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.

Authors:  Jonathan G Howlett; Robert S McKelvie; J Malcolm O Arnold; Jeannine Costigan; Paul Dorian; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Philip Jong; Simon Kouz; Peter Liu; Elizabeth Mann; Gordon W Moe; Ross T Tsuyuki; Heather J Ross; Michel White
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

10.  Effects of docosahexaenoic Acid supplementation on blood pressure, heart rate, and serum lipids in Scottish men with hypertension and hypercholesterolemia.

Authors:  Miki Sagara; Marina Njelekela; Takanori Teramoto; Takashi Taguchi; Mari Mori; Lesley Armitage; Nina Birt; Christopher Birt; Yukio Yamori
Journal:  Int J Hypertens       Date:  2011-03-08       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.